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ABSTRACT 
Objective: Eremurus himalaicus Baker, an edible herb of North Western Himalayas, has not been scientifically assessed for hepatoprotective 
potential. The ethyl acetate extract (EHE), methanolic extract (EHM) and aqueous extract (EHA) of Eremurus himalaicus were therefore evaluated 
for potential hepatoprotective activity in Wistar strain albino rats.  
Methods: Carbon tetrachloride (1.5 ml/kg) was employed as hepatotoxin and was given on Day 1 of the experiment. The extracts at a dose of 300 
mg/kg bw (EHE, EHM and EHA) and the standard at a dose of 10 mg/kg bw (Liv 52) were given for following 7 d and the biochemical parameters 
(SGOT, SGPT, ALP, TP, bilirubin and UA) were estimated in order to assess the liver function. Moreover, the liver tissue samples were examined for 
histopathological changes.  
Results: The results for serum biochemical analysis in rats showed a rise in SGOT, SGPT, ALP and bilirubin levels and a decrease in TP and UA levels 
upon giving hepatotoxin. The administration of the extracts and standard drug, for a period of 7 d, showed a significant decrease in SGOT, SGPT, ALP 
and bilirubin levels and an increase in TP and UA levels for EHM when compared to the toxic group. These results correlated well with the 
histopathological findings of liver for normal, toxic and extract treated groups. The EHM treatment decreased the extent of fat deposition and 
necrosis caused by CCl4
Conclusion: Collectively; the results indicate that EHM exhibits significant hepatoprotective activity against CCl
. The results were almost similar to the standard drug Liv 52.  
4 
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The liver is a vital organ in our body which not only plays a role in 
various physiological functions but also protects our body against 
the ill effects of drugs and chemicals; endogenous as well as 
exogenous. Some of these drugs and chemicals act as hepatotoxic 
agents and induce various liver disorders [1]. Hepatic problems are 
accountable for a number of deaths worldwide. There has been a 
remarkable scientific advancement in the field of hepatology, however, 
the pharmacotherapeutic options available for hepatic disorders are 
very inadequate and hence the requirement for the development of 
new hepatoprotective drugs is the need of the hour [2]. 
Synthetic drugs available in the market come with severe undesirable 
side effects which lead to the growing demand to focus on 
ethnopharmacological approaches of drug discovery. Traditional 
medical practitioners have been using plant extracts for the treatment of 
liver disorders for centuries [3, 4]. Also, a number of plant extracts have 
been shown to protect against CCl4
Eremurus himalaicus (Himalayan Desert Candle) is a plant that can 
be easily identified by its tall, stout, spike-like cluster of hundreds of 
white flowers with protruding orange anthers [5]. The edible herb, 
Eremurus himalaicus is found on rocky slopes of the drier areas of 
the Himalayas at altitudes of 2100-3300 m asl. The local names of 
this plant are Kaihloon, Hulla, Dharshaag, Bulkutor Yalun and Chhil 
haak. Its leaves and roots are consumed as food. The leaves are 
cooked as a vegetable [6-8]. When the leaves are young, these are 
consumed in the treatment of anemia [9]. Also, its leaves are widely 
used as a galactagogue by practitioners of traditional systems of 
medicines [10]. It is an almost unexplored plant as far as the 
screening of various biological activities is concerned. This study is 
aimed at adding to the biological activity profile of this plant besides 
providing a new hepatoprotective drug to the mankind. The 
amelioration of CCl
 induced hepatotoxicity. However, a 
lot of plants are still unexplored and need to be worked upon. 
4
MATERIALS AND METHODS 
 induced hepatotoxicity by this plant has not 
been evaluated yet and this study is the first step in this direction. 
Chemicals and solvents 
All the solvents, drugs and chemicals (used in the study were 
obtained commercially and were of analytical grade. The solvents 
(ethyl acetate, methanol) were acquired from MERCK; the chemicals 
(CCl4
Plant material collection and identification 
, liquid paraffin) were acquired from MERCK and Sigma-
Aldrich; the standard drug (Liv 52) manufactured by Himalaya 
Herbal Health Care was acquired from the local drug store, and the 
autoanalyser kits were acquired from Erba. 
The first step was the collection of the plant from Faqir Goojree area 
of Dhara, Srinagar, Kashmir at the proper time (in the month of 
May). The collected plant material was properly identified and the 
specimen voucher was deposited in The Centre for Biodiversity and 
Taxonomy, Department of Botany, University of Kashmir under 
herbarium number: 1765 (KASH). 
Extraction 
The coarsely powdered plant material was extracted sequentially 
with different solvents of increasing polarity (petroleum ether, ethyl 
acetate, methanol and distilled water) by soxhlet extraction method. 
The recovered extracts were filtered and concentration of filtrate 
was done under reduced pressure at 35-45° and finally the dried 
extracts were stored at 4 o
Experimental animals 
C in well-labeled storage vials for further 
experimental use [11]. 
Wistar rats of both sexes weighing 150–200 g were employed for the 
study. The animals were procured from The Central Animal House of 
Indian Institute of Integrative Medicine (IIIM) Jammu. The animals 
were fed with standard diet and water was provided ad libitium. The 
animals were maintained at standard conditions under the approval 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                  Vol 8, Issue 9, 2016 
Ganai et al.  
Int J Pharm Pharm Sci, Vol 8, Issue 9, 24-27 
 
25 
of the Institutional Animal Ethics Committee (IAEC) Department of 
Pharmaceutical Sciences, Faculty of Applied Sciences and 
Technology, University of Kashmir, Srinagar (Registration No. 
F(IAEC-Approval)KU/2015/14; dated: 21-08-2015). 
Acute toxicity testing and dose selection 
The acute toxicity testing was performed as per Organization for 
Economic Cooperation and Development (OECD) guidelines no 425. 
Healthy Wistar strain male albino rats were used for the study. As 
per the guidelines, the only limit test was performed since the plant 
is locally used as a vegetable. The dose selection was done on the 
basis of the result of acute toxicity test; a random value that was less 
than the LD50
On Day 8 the blood samples were withdrawn by orbital plexus 
puncturing and the rats were sacrificed by decapitation. The blood 
samples were allowed to clot for 30-40 min. at room temperature 
and serum was separated by centrifugation at 2500 rpm for 15 min. 
and various biochemical parameters were estimated. The liver 
tissue samples were sent for histopathological studies. 
 value was selected so that no toxic effect would be 
exerted by the extracts. 
Administration of hepatotoxin 
Carbon tetrachloride mixed with liquid paraffin in a ratio of 1:1 was 
employed as hepatotoxin and was administered intraperitoneally (i. 
p) to each rat at a dose of 1.5 ml/kg body weight. 
Antihepatotoxic activity 
The antihepatotoxic activity was screened using the standard 
methodologies [12, 13]. The experimental animals were divided into 
six groups, each group consisting of 5 rats. Group (I) which served as 
normal control received normal saline per orally (p. o). Group (II) 
which served as toxic control group received hepatotoxin on Day 1 
to produce toxicity in the liver. Group (III) was given a single dose of 
hepatotoxin and then Liv 52 (100 mg/kg b. w, p. o) was given for 7 d. 
Group (IV-VI) received a single dose of hepatotoxin on Day 1 and a 
daily dose of EHE, EHM and EHA (300 mg/kg b. w, p. o) for 7 d 
respectively. 
Biochemical parameters 
The biochemical parameters that were estimated in order to assess 
the liver function included serum glutamic oxaloacetetic 
transaminase (SGOT) or AST, serum glutamic pyruvate 
transaminase (SGPT) or ALT, alkaline phosphatase (ALP), total 
proteins (TP), bilirubin and uric acid (UA) [12, 13]. Their levels were 
analyzed on Sysmex autoanalyser. 
Histopathological studies 
The liver tissue samples were fixed in 10% formalin solution. This 
was followed by dehydration in graded alcohol and then the samples 
were embedded in paraffin. This was followed by sectioning on a 
microtome, followed by staining with a haematoxylin-eosin dye. 
Then the slides were taken for histopathological examination. 
Statistical analysis 
The data obtained for the serum biochemical parameters was 
represented as mean±S. E (n=5). For determination of statistical 
significance, one-way analysis of variance (ANOVA) followed by 
Tukey’s test was employed. P values of less than 0.05 were 
considered significant. 
RESULTS 
The effect of Eremurus himalaicus on serum marker enzymes is 
presented in table 1 and table 2. The levels of serum SGOT, SGPT, ALP 
and bilirubin markedly elevated upon administration of CCl4
 
 as 
indicated by levels of these enzymes in the toxic group. The levels of total 
protein and uric acid decreased in CCl4 treated animals. These changes 
were statistically significant when compared to the normal (p<0.0001). 
The increase in the levels of these enzymes indicated liver damage. 
Table 1: Effect of Eremurus himalaicus on SGOT, SGPT, ALP and bilirubin levels 
Group SGOT (U/l) SGPT (U/l) ALP (U/l) Bilirubin (mg/dL) 
Normal 69.21±2.53 57.51±5.93 68.3±4.27 0.98±0.05 
Toxic control 176.14±2.92 177.17±5.76a 130.24±5.23a a 2.35±0.05
Standard 
a 
72.61±3.68 60.02±5.51b 75.91±6.90b 1.03±0.03b 
EHM 
b 
75.52±4.23 66.81±3.07b 77.22±4.61b 1.06±0.03b 
EHE 
b 
168.1±3.54 163.42±2.98a,c,e 119.17±6.64a,c,e 2.31±0.04a,d,e 
EHA 
a,e 
170.61±4.11 169.4±4.96a,e 125.78±5.72a,e 2.39±0.03a,e a,e 
Values expressed as mean±SD, n=6, One way ANOVA followed by Tukey’s multiple comparison post hoc test, aP<0.0001 when compared with normal 
group; bP<0.0001, c P<0.01, d P<0.05 when compared with toxic group; e
 
 P<0.0001 when compared with standard group, EHM stands for Eremurus 
himalaicus methanol extract; EHE stands for Eremurus himalaicus ethyl acetate extract; EHA stands for Eremurus himalaicus aqueous extract 
Table 2: Effect of Eremurus himalaicus on total protein and uric acid levels 
Group Total protein (mg/dL) Uric acid (mg/dL) 
Normal 6.95±0.06 2.8±0.05 












6.3±0.06 1.37±0.05a,c a,c 
Values expressed as mean±SD, n=6, One way ANOVA followed by Tukey’s multiple comparison post hoc test, a P<0.0001 when compared with 
normal group; b P<0.0001 when compared with toxic group; c
 
 P<0.0001 when compared with standard group, EHM stands for Eremurus himalaicus 
methanol extract; EHE stands for Eremurus himalaicus ethyl acetate extract; EHA stands for Eremurus himalaicus aqueous extract 
The different extracts of Eremurus himalaicus (EHE, EHM and EHA), 
at a dose of 300 mg/kg bw respectively, were administered to the 
rats in order to find out their protective effect on liver damage 
caused by hepatotoxin CCl4
The effect of EHE on the values of serum marker enzymes SGOT 
(p<0.01), SGPT (p<0.01) and ALP (p<0.05) was also significant; 
however, the values were non-significant for bilirubin, total protein, 
. As is evident from the tables, EHM 
showed a highly significant decrease in the levels of serum SGOT 
(p<0.0001), SGPT (p<0.0001), ALP (p<0.0001) and bilirubin 
(p<0.0001) and also a highly significant increase in total protein 
(p<0.0001) and uric acid levels (p<0.0001) when compared to toxic 
group. These values were non-significant when compared to the 
values obtained for normal group and standard group (Liv 52), 
which implies that EHM and Liv 52 exhibit almost similar 
hepatoprotective efficacies.  
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and uric acid when compared to the toxic group. The values were 
significant for all the enzymes when compared to normal group and 
standard treated group, which implies that the effect of EHE on 
hepatoprotection is much less than that of the standard drug Liv 52. 
The results for EHA revealed that it has no hepatoprotective 
potential as the values were significant for all the marker enzymes 
when compared to normal and standard treated groups. Also, the 







Fig. 1: Micrographs of rat liver sections of,  
(A1) Normal group at low power; (A2) Normal group at high power; 
(B1) Toxic group at low power; (B2) Toxic group at high power; (C1) 
Ethyl acetate extract treated group at low power; (C2) Ethyl acetate 
extract treated group at high power; (D1) Methanol extract treated 
group at low power; (D2) Methanol extract treated group at high 
power; (E1) Standard treated group at low power; and (E2) 
Standard treated group at high power 
 
The histopathological studies were also in concurrence with the 
results obtained for biochemical parameters. There was evident 
hepatocellular damage in the toxic group in comparison to the 
normal group. The standard treated group showed prevention of the 
histopathological aberrations caused due to CCl4
DISCUSSION 
. Amongst the 
extract treated groups, the group treated with EHM showed utmost 
recovery of hepatocytes which indicates its hepatoprotective 
potential. The group treated with EHE also showed discernible 
recovery; however, it was much less in comparison to EHM. The 
photomicrographic representations of the liver tissues of the 
respective groups are shown in fig. 1. 
Any damage to the liver, which is related to altered or impaired 
functioning of the liver and is caused due to drug exposure or 
exposure to other noninfectious agents is defined as hepatotoxicity 
[11, 1]. 
In order to study the mechanism of hepatotoxicity and/or drug 
discovery for prevention of hepatotoxicity, various chemical toxins 
are used as the mock-up substances for causing hepatocyte damage. 
These substances include carbon tetrachloride, acetaminophen, 
thioacetamide and galactosamine [12-15]. The mechanisms by 
which these substances produce liver damage are different; 
however, the damage caused by these hepatotoxins is evaluated 
through the same parameters. 
The carbon tetrachloride induced hepatotoxicity has probably been 
most extensively studied from both biochemical and pathological 
perspectives which provides an idea about its mechanism of toxicity 
[16-18]. CCl4 exerts its effect through trichloromethyl radical which 
gets bound to the cellular macromolecules and causes damage to the 
endoplasmic reticulum membrane lipids and causes leakage of 
enzymes [19, 20]. Elevated levels of serum enzymes indicate that 
there is a loss of functional integrity of the cell membrane and hence 
cellular leakage due to toxicity produced by CCl4
In the present work, CCl
 [21]. 
4 induced hepatocyte damage which was 
evident from the increase in the serum marker enzymes SGOT, SGPT, 
ALP and bilirubin and a decrease in total protein and uric acid levels. 
The administration of a methanolic extract of Eremurus himalaicus 
and the standard drug Liv 52 caused a significant (P<0.0001) 
restoration of serum levels of these enzymes. The ethyl acetate 
extract also showed some restoration of the enzyme levels. This 
reversal of increased levels of serum enzymes by Eremurus 
himalaicus extracts may be due to various reasons which lead to 
membrane stabilization and hence prevent the leakage of 
intracellular contents. Another reason may be that it prevents 
hepatocyte damage and induces hepatocyte regeneration. This can 
be assumed on the basis of histopathological reports in which it was 
clear that the CCl4 treated group showed degenerative changes, 
whereas, the standard and extract treated groups showed not as 
much of degenerative changes. This provided further insight into the 
hepatoprotective effect of Eremurus himalaicus. Moreover, this plant 
has been reported to contain flavonoids, which are known to 
possess hepatoprotective activity [22, 23]. Also, various studies have 
revealed that the plant extracts having antioxidant activity may 
protect against CCl4
CONCLUSION 
 induced hepatotoxicity; this occurs via 
inhibition of lipid peroxidation and enhancement of activity of 
antioxidant enzymes [24, 25]. Therefore, this may be considered as 
another reason for the hepatoprotective activity of this plant. 
Further studies are in progress to characterize the bioactive 
principles from this plant. 
It can be concluded from the present study that the methanolic 
extract, and to some extent the ethyl acetate extract, of Eremurus 
himalaicus show a protective effect on the CCl4
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 induced liver damage 
as revealed by the biochemical and histopathological studies. This 
effect was found to be quite comparable to the standard 
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